BSE filing, BSE: 543848. Summary written from the filing by ALFA Finder's alert engine.
Dev Labtech Venture Ltd: key numbers
- Share price
- ₹22.90
- Market cap
- ₹108.7 Cr
- Revenue (annual)
- ₹167.2 Cr
- Net profit (annual)
- ₹9.57 Cr
- P/E (TTM)
- 11.4×Sector 49.0×
- Promoter holding
- 56.69%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dev Labtech Venture Ltd
All →Dev Labtech Venture Other Announcement
Dev Labtech Venture Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Dev Labtech Venture Convertible Warrants
Dev Labtech Venture will hold an EGM to approve the preferential issue of 1.37 crore convertible warrants, raising ₹17.81 Crore.
- Value
- ₹17.81 Cr
Dev Labtech Venture Capital Structure Change
Dev Labtech Venture Limited announced an increase in authorized share capital from 50 million to 62 million equity shares, each with a face value of Rs 5.
Dev Labtech Venture Fund Raise of ₹17.81 Cr
Dev Labtech Venture approved the preferential issue of 1.37 crore convertible warrants aggregating ₹17.81 crore. The company also increased its authorised share capital for future expansion.
- Value
- ₹17.81 Cr
Dev Labtech Venture Board Meeting Date
Dev Labtech Venture Ltd has scheduled a board meeting for October 7, 2026, to discuss raising funds via preferential allotment and increasing authorized share capital.
Dev Labtech Venture Annual General Meeting
Dev Labtech Venture Limited held its 33rd Annual General Meeting on September 26, 2026. Members considered the adoption of financial statements, director appointment, and related party transactions.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.